171 related articles for article (PubMed ID: 16724101)
1. In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.
Negrin RS; Contag CH
Nat Rev Immunol; 2006 Jun; 6(6):484-90. PubMed ID: 16724101
[TBL] [Abstract][Full Text] [Related]
2. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging.
Mandl S; Schimmelpfennig C; Edinger M; Negrin RS; Contag CH
J Cell Biochem Suppl; 2002; 39():239-48. PubMed ID: 12552623
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of leukocyte trafficking in blood vessels and tissues.
Mempel TR; Scimone ML; Mora JR; von Andrian UH
Curr Opin Immunol; 2004 Aug; 16(4):406-17. PubMed ID: 15245733
[TBL] [Abstract][Full Text] [Related]
4. B-cell involvement in chronic graft-versus-host disease.
Kapur R; Ebeling S; Hagenbeek A
Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell homeostasis and trafficking in transplantation.
Merad M; Collin M; Bromberg J
Trends Immunol; 2007 Aug; 28(8):353-9. PubMed ID: 17618832
[TBL] [Abstract][Full Text] [Related]
6. Progress in acute graft versus host disease.
Holler E
Curr Opin Hematol; 2007 Nov; 14(6):625-31. PubMed ID: 17898566
[TBL] [Abstract][Full Text] [Related]
7. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging.
Brutkiewicz S; Mendonca M; Stantz K; Comerford K; Bigsby R; Hutchins G; Goebl M; Harrington M
Luminescence; 2007; 22(3):221-8. PubMed ID: 17286245
[TBL] [Abstract][Full Text] [Related]
8. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.
Cohen JL; Boyer O
Curr Opin Immunol; 2006 Oct; 18(5):580-5. PubMed ID: 16879951
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging using visible light to reveal biological changes in the brain.
Contag CH
Neuroimaging Clin N Am; 2006 Nov; 16(4):633-54, ix. PubMed ID: 17148024
[TBL] [Abstract][Full Text] [Related]
10. Advances in the understanding of acute graft-versus-host disease.
Morris ES; Hill GR
Br J Haematol; 2007 Apr; 137(1):3-19. PubMed ID: 17359368
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease.
Li H; Guo Z; Jiang X; Zhu H; Li X; Mao N
Stem Cells; 2008 Oct; 26(10):2531-41. PubMed ID: 18635870
[TBL] [Abstract][Full Text] [Related]
12. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
Song J; Ito T; Matsuda C; Miao G; Tanemura M; Nishida T; Nozawa M; Matsuda H; Sawa Y
Clin Exp Immunol; 2006 Oct; 146(1):85-92. PubMed ID: 16968402
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelium and graft-versus-host disease.
Biedermann BC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
[TBL] [Abstract][Full Text] [Related]
15. Predominant infiltration of monocytes in chronic graft-versus-host disease.
Namba N; Shinagawa K; Fujii N; Maeda Y; Ishimaru F; Ikeda K; Matsui T; Tanimoto M; Katayama Y
Transplantation; 2007 Jan; 83(2):220-4. PubMed ID: 17264819
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
17. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Follicular graft-versus-host disease: a rare manifestation of chronic cutaneous graft-versus-host disease.
Martí N; Martin JM; Monteagudo C; López V; Jordá E
Am J Dermatopathol; 2008 Dec; 30(6):620-1. PubMed ID: 19033942
[TBL] [Abstract][Full Text] [Related]
20. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Duran-Struuck R; Reddy P
Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
